Recombinant Human TSPO Protein，His

Translocator protein (TSPO), previously known as the peripheral-type benzodiazepine receptor, has gained significant interest in the field of biomedical research due to its pivotal role in various physiological and pathological processes. TSPO is predominantly located in the outer mitochondrial membrane and is involved in the regulation of cholesterol transport, steroidogenesis, and apoptosis. Its expression is upregulated in response to cellular stress, inflammation, and neurodegeneration, making it a potential biomarker for various diseases, including cancer, neurodegenerative disorders, and psychiatric conditions. The development of TSPO as a target for therapeutic interventions has further propelled research into its structure and function. Recombinant TSPO proteins are essential for studying the molecular mechanisms, interactions, and signaling pathways associated with this protein. Additionally, the creation of TSPO knockout and transgenic animal models has provided valuable insights into its physiological roles and the implications of TSPO dysregulation. As TSPO is implicated in the manifestation of a range of diseases, understanding its biology through recombinant protein studies offers the potential for novel diagnostic and therapeutic strategies, including TSPO ligands that could modulate its activity or serve as imaging agents in disease contexts. The ongoing exploration of TSPO's role in health and disease underscores its significance as a target for future biomedical research and clinical applications.